Table 4.

Effect of GLP1-RA versus control on metabolic parameters: (a) Weight, (b) HBA1c, and (c) TG.

Study name	Subgroup within study	Std diff in means	95% CI	p-value	Relative weightage (%)
DLIFT	Weight	− 0.66	− 1.16 to − 0.15	0.01	18.28
Liu et al	Weight	− 0.98	− 1.47 to − 0.48	< 0.01	19.08
Shao et al	Weight	− 0.90	− 1.42 to − 0.36	< 0.01	16.42
Tang et al	Weight	− 0.76	− 1.45 to − 0.08	0.02	9.81
Tian et al	Weight	− 0.36	− 0.72 to − 0.01	0.04	36.41
Combined effect size	Weight	− 0.66	− 0.88 to − 0.44	< 0.01	Heterogeneity (I2): 22.35
DLIFT	HBA1c	− 0.27	− 0.76 to 0.22	0.28	18.46
Liu et al	HBA1c	− 0.86	− 1.34 to − 0.36	< 0.01	18.94
Shao et al	HBA1c	− 0.50	− 1.01 to 0.02	0.06	16.95
Tang et al	HBA1c	− 0.22	− 0.88 to 0.44	0.52	10.12
Tian et al	HBA1c	− 0.24	− 0.58 to 0.12	0.20	35.53
Combined effect size	HBA1c	− 0.40	− 0.61 to − 0.19	< 0.01	Heterogeneity (I2): 17.91
DLIFT	TG	− 0.30	− 0.79 to 0.19	0.23	16.12
Dutour et al	TG	− 0.36	− 0.96 to 0.22	0.22	11.02
Liu et al	TG	− 0.12	− 0.59 to 0.34	0.58	18.04
Shao et al	TG	− 0.50	− 1.01 to 0.02	0.06	14.83
Tang et al	TG	− 0.43	− 1.10 to 0.24	0.20	8.70
Tian et al	TG	− 0.02	− 0.37 to 0.33	0.91	31.28
Combined effect size	TG	− 0.22	− 0.42 to − 0.03	0.02	Heterogeneity (I2): 0.00

CI confidence interval.